Cargando…
ERCC1–XPF targeting to psoralen–DNA crosslinks depends on XPA and FANCD2
The effectiveness of many DNA-damaging chemotherapeutic drugs depends on their ability to form monoadducts, intrastrand crosslinks and/or interstrand crosslinks (ICLs) that interfere with transcription and replication. The ERCC1–XPF endonuclease plays a critical role in removal of these lesions by i...
Autores principales: | Sabatella, Mariangela, Pines, Alex, Slyskova, Jana, Vermeulen, Wim, Lans, Hannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228994/ https://www.ncbi.nlm.nih.gov/pubmed/31392348 http://dx.doi.org/10.1007/s00018-019-03264-5 |
Ejemplares similares
-
Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features
por: Sabatella, Mariangela, et al.
Publicado: (2018) -
XPF–ERCC1: Linchpin of DNA crosslink repair
por: McHugh, Peter J.
Publicado: (2020) -
RPA activates the XPF‐ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks
por: Abdullah, Ummi B, et al.
Publicado: (2017) -
Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage
por: Slyskova, Jana, et al.
Publicado: (2018) -
Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks
por: Thoma, Brian S., et al.
Publicado: (2005)